DOCSLIB.ORG

Ergostenol Glycoside Derivatives Inhibit the Expression of Inflammatory Mediators and Matrix Metalloproteinase

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ergostenol Glycoside Derivatives Inhibit the Expression of Inflammatory Mediators and Matrix Metalloproteinase molecules Communication D8(14)-Ergostenol Glycoside Derivatives Inhibit the Expression of Inflammatory Mediators and Matrix Metalloproteinase Hyejin Moon 1,†, Myoungsil Ko 1,†, Yujin Park 2,†, Jeonguk Kim 1, Dowon Yoon 1, Eunjoohwang Lee 2, Taehoon Lee 1,* and Hakwon Kim 1,* 1 Global Center for Pharmaceutical Ingredient Materials, Department of Applied Chemistry, Kyung Hee University, Yongin 17104, Korea; [email protected] (H.M.); [email protected] (M.K.); [email protected] (J.K.); [email protected] (D.Y.) 2 Graduate School of East-West Medicinal Science, Kyung Hee University, Yongin 17104, Korea; [email protected] (Y.P.); [email protected] (E.L.) * Correspondence: [email protected] (T.L.); [email protected] (H.K.); Tel.: +823-1201-5317 (T.L.); +823-1201-2459 (H.K.) † These authors equally contribute to this work. Abstract: Arthritis is a chronic inflammatory disease accompanied by pathological reactions such as swelling, redness, fever, and pain in various joint areas. The drugs currently available to treat arthritis are associated with diverse side-effects. Therefore, there is a need for safer and more effective treatments to alleviate the inflammation of arthritis with fewer side-effects. In this study, a new sterol, D8(14)-ergostenol, was discovered, and its glycosides were synthesized and found to be more efficient in terms of synthesis or anti-inflammatory activity than either spinasterol or 5,6-dihydroergosterol is. Among these synthetic glycosides, galactosyl ergostenol inhibited the expression of inflammatory mediators in TNF-α-stimulated FLS and TNF-α-induced MMPs and collagen type II A1 degradation Citation: Moon, H.; Ko, M.; Park, Y.; in human chondrocytes. These results suggest the new galactosyl ergostenol as a treatment candidate Kim, J.; Yoon, D.; Lee, E.; Lee, T.; for arthritis. Kim, H. D8(14)-Ergostenol Glycoside Derivatives Inhibit the Expression of Keywords: ergostenol; ergostenol glycosides; arthritis; matrix metalloproteinase; collagen type II A1 Inflammatory Mediators and Matrix Metalloproteinase. Molecules 2021, 26, 4547. https://doi.org/10.3390/ molecules26154547 1. Introduction Arthritis is a chronic inflammatory disease accompanied by pathological reactions Academic Editor: Michael John Plater such as swelling, redness, fever, and pain in various joint areas [1–4]. Joints are areas where two or more bones meet, and most of them are responsible for helping the body move [2]. Received: 1 July 2021 In terms of anatomy, the structure of a joint is composed of cartilage, which protects the Accepted: 23 July 2021 Published: 28 July 2021 end of the bone, and a synovial membrane that secretes a clear sticky fluid around the joint [3]. Joint tissue inflammation is classified as either degenerative osteoarthritis (OA) or Publisher’s Note: MDPI stays neutral rheumatoid arthritis (RA) according to the loss of cartilage and autoimmune dysfunction with regard to jurisdictional claims in of the synovial membrane [4]. published maps and institutional affil- The major cause of OA is age-related damage to chondrocytes. The primary patho- iations. logical mechanism of OA is the reduced formation of the extracellular matrix of articular cartilage cells and the alteration of the extracellular matrix components of cartilage due to cellular aging [5]. Normal chondrocytes play an important role in cartilage homeostasis. Abnormal chondrocytes exposed to inflammatory cytokines and chemokines cause the excessive secretion of several types of matrix-degrading enzymes such as matrix metal- Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. loproteinases (MMPs). These MMPs break down collagen type II A1 (COL2A1), a major This article is an open access article collagen component of the cartilage matrix. In particular, MMP-1, MMP-3, and MMP-13 distributed under the terms and play a major role in arthritis [6–8]. Rheumatoid arthritis is a chronic inflammatory condi- conditions of the Creative Commons tion that arises in the synovial membrane surrounding the joints. The major pathogenic Attribution (CC BY) license (https:// mechanism of RA is the excessive secretion of inflammatory cytokines and chemokines creativecommons.org/licenses/by/ due to immune abnormalities, leading to the gradual destruction of cartilage tissue with an 4.0/). increased production of matrix degradation enzymes such as MMPs [9]. Molecules 2021, 26, 4547. https://doi.org/10.3390/molecules26154547 https://www.mdpi.com/journal/molecules Molecules 2021, 26, x 2 of 12 Molecules 2021, 26, 4547 due to immune abnormalities, leading to the gradual destruction of cartilage tissue2 with of 12 an increased production of matrix degradation enzymes such as MMPs [9]. The major constituents of the cartilage matrix are COL2A1 and proteoglycans. De- generative osteoarthritis and rheumatoid arthritis are caused by the degradation of COL2A1,The major which constituents is primarily of mediated the cartilage by matrixMMP-1, are MMP-3, COL2A1 and and MMP-13. proteoglycans. These Degen-MMPs erative osteoarthritis and rheumatoid arthritis are caused by the degradation of COL2A1, are secreted mainly by human chondrocytes (HCs) and human fibroblast-like synovio- which is primarily mediated by MMP-1, MMP-3, and MMP-13. These MMPs are secreted cytes (FLSs) [4]. The over-expression of MMPs such as MMP-1, MMP-3, and MMP-13 mainly by human chondrocytes (HCs) and human fibroblast-like synoviocytes (FLSs) [4]. leads to a vicious cycle of the activation of inflammatory cytokines and chemokines [10]. The over-expression of MMPs such as MMP-1, MMP-3, and MMP-13 leads to a vicious cycle Regulating these inflammatory mediators can alleviate symptoms of arthritis. Currently, of the activation of inflammatory cytokines and chemokines [10]. Regulating these inflam- various drugs, including steroidal, nonsteroidal, and biological materials with analgesic matory mediators can alleviate symptoms of arthritis. Currently, various drugs, including or anti-inflammatory properties, are used to treat arthritis [11]. These drugs generally steroidal, nonsteroidal, and biological materials with analgesic or anti-inflammatory prop- have a short duration of effect and low efficacy, and they can cause many side effects erties, are used to treat arthritis [11]. These drugs generally have a short duration of when used long term [12,13]. Thus, there is a need for safer and more effective arthritis effect and low efficacy, and they can cause many side effects when used long term [12,13]. treatments to alleviate joint inflammation and inhibit COL2A1 degradation through inhi- Thus, there is a need for safer and more effective arthritis treatments to alleviate joint inflammationbition of MMPs. and inhibit COL2A1 degradation through inhibition of MMPs. Previously,Previously, we we reported reported the the potent potent anti-inflammatory anti-inflammatory activity activity of of 5,6-dihydroergosterol 5,6-dihydroergoste- glucoserol glucose (DHE-Glu, (DHE-Glu,2a), 2a a), synthetic a synthetic compound compound derived derived from from a a natural natural product,product, spinas-spinas- terolterol glucoseglucose (Spin-Glu, 1a1a))[ [14].14]. In In HaCaT HaCaT cells, cells, DHE-Glu DHE-Glu (2a (2a) produced) produced strong strong anti-in- anti- inflammatoryflammatory activity activity through through the the inhibition ofof TNF-TNF-αα/IFN-/IFN-γ-induced-induced expressionsexpressions ofof CCL17CCL17 andand CCL22,CCL22, andand alsoalso inhibitedinhibited DNCB-inducedDNCB-induced contactcontact dermatitisdermatitis inin anan animalanimal modelmodel of chronic chronic inflammation inflammation [15]. [15]. As As a follow-up a follow-up to this to this study, study, we wetried tried to find to finda new a newsynthetic synthetic sterol sterolthat could that be could synthesized be synthesized more efficiently more efficiently and/or had and/or a greater had bioactivity a greater bioactivitythan spinasterol than spinasterol(Spin, 1) or (Spin, 5,6-dihydroergosterol1) or 5,6-dihydroergosterol (DHE, 2) (DHE,did. As2 )a did. result, As aΔ result,8(14)-er- Dgostenol8(14)-ergostenol (Ergn, 3 (Ergn,), a sterol3), ahaving sterol havinga double a doublebond at bond carbon at carbonposition position 8(14) of 8(14) the steroid of the steroidskeleton, skeleton, was identified was identified as a candidate as a candidate compound. compound. This sterol This sterolcan be can synthesized be synthesized from fromergosterol ergosterol by selective by selective hydrogenation hydrogenation followed followed by double by double bond bond migration migration [16]. [We16]. syn- We synthesizedthesized ergostenol ergostenol glycosides glycosides containing containing a asu sugar,gar, such such as as glucose, glucose, galactose, galactose, or xylose, byby SchmidtSchmidt glycosylationglycosylation ofof ErgnErgn ((33)) withwith aa glycosylglycosyl imidate.imidate. SpinSpin ((11),), Spin-GluSpin-Glu ((1a1a),), DHEDHE ((22),), DHE-GluDHE-Glu ((2a2a),), ErgnErgn ((33),), andand ergostenolergostenol glycosidesglycosides includingincluding Ergn-GluErgn-Glu ((3a3a),), Ergn-GalErgn-Gal ((3b3b),), andand Ergn-XylErgn-Xyl ((3c3c)) areare shownshown inin FigureFigure1 1.. In In this this study, study, newly newly synthesized synthesized ergostenol ergostenol glycosidesglycosides werewere testedtested forfor anti-inflammatoryanti-inflammatory propertiesproperties inin FLSsFLSs andand thethe suppressionsuppression ofof MMPsMMPs expressionexpression inin HCs. HCs. These These results results may may suggest suggest the the possibility possibility of beingof being
Load more

Recommended publications
  • Studies on Betalain Phytochemistry by Means of Ion-Pair Countercurrent Chromatography
    STUDIES ON BETALAIN PHYTOCHEMISTRY BY MEANS OF ION-PAIR COUNTERCURRENT CHROMATOGRAPHY Von der Fakultät für Lebenswissenschaften der Technischen Universität Carolo-Wilhelmina zu Braunschweig zur Erlangung des Grades einer Doktorin der Naturwissenschaften (Dr. rer. nat.) genehmigte D i s s e r t a t i o n von Thu Tran Thi Minh aus Vietnam 1. Referent: Prof. Dr. Peter Winterhalter 2. Referent: apl. Prof. Dr. Ulrich Engelhardt eingereicht am: 28.02.2018 mündliche Prüfung (Disputation) am: 28.05.2018 Druckjahr 2018 Vorveröffentlichungen der Dissertation Teilergebnisse aus dieser Arbeit wurden mit Genehmigung der Fakultät für Lebenswissenschaften, vertreten durch den Mentor der Arbeit, in folgenden Beiträgen vorab veröffentlicht: Tagungsbeiträge T. Tran, G. Jerz, T.E. Moussa-Ayoub, S.K.EI-Samahy, S. Rohn und P. Winterhalter: Metabolite screening and fractionation of betalains and flavonoids from Opuntia stricta var. dillenii by means of High Performance Countercurrent chromatography (HPCCC) and sequential off-line injection to ESI-MS/MS. (Poster) 44. Deutscher Lebensmittelchemikertag, Karlsruhe (2015). Thu Minh Thi Tran, Tamer E. Moussa-Ayoub, Salah K. El-Samahy, Sascha Rohn, Peter Winterhalter und Gerold Jerz: Metabolite profile of betalains and flavonoids from Opuntia stricta var. dilleni by HPCCC and offline ESI-MS/MS. (Poster) 9. Countercurrent Chromatography Conference, Chicago (2016). Thu Tran Thi Minh, Binh Nguyen, Peter Winterhalter und Gerold Jerz: Recovery of the betacyanin celosianin II and flavonoid glycosides from Atriplex hortensis var. rubra by HPCCC and off-line ESI-MS/MS monitoring. (Poster) 9. Countercurrent Chromatography Conference, Chicago (2016). ACKNOWLEDGEMENT This PhD would not be done without the supports of my mentor, my supervisor and my family.
    [Show full text]
  • "Ellagic Acid, an Anticarcinogen in Fruits, Especially in Strawberries: a Review"
    FEATURE Ellagic Acid, an Anticarcinogen in Fruits, Especially in Strawberries: A Review John L. Maasl and Gene J. Galletta2 Fruit Laboratory, U.S. Department of Agriculture, Agricultural Research Service, Beltsville, MD 20705 Gary D. Stoner3 Department of Pathology, Medical College of Ohio, Toledo, OH 43699 The various roles of ellagic acid as an an- digestibility of natural forms of ellagic acid, Mode of inhibition ticarcinogenic plant phenol, including its in- and the distribution and organ accumulation The inhibition of cancer by ellagic acid hibitory effects on chemically induced cancer, or excretion in animal systems is in progress appears to occur through the following its effect on the body, occurrence in plants at several institutions. Recent interest in el- mechanisms: and biosynthesis, allelopathic properties, ac- lagic acid in plant systems has been largely a. Inhibition of the metabolic activation tivity in regulation of plant hormones, for- for fruit-juice processing and wine industry of carcinogens. For example, ellagic acid in- mation of metal complexes, function as an applications. However, new studies also hibits the conversion of polycyclic aromatic antioxidant, insect growth and feeding in- suggest that ellagic acid participates in plant hydrocarbons [e.g., benzo (a) pyrene, 7,12- hibitor, and inheritance are reviewed and hormone regulatory systems, allelopathic and dimethylbenz (a) anthracene, and 3-methyl- discussed in relation to current and future autopathic effects, insect deterrent princi- cholanthrene], nitroso compounds (e.g., N- research. ples, and insect growth inhibition, all of which nitrosobenzylmethylamine and N -methyl- N- Ellagic acid (C14H6O8) is a naturally oc- indicate the urgent need for further research nitrosourea), and aflatoxin B1 into forms that curring phenolic constituent of many species to understand the roles of ellagic acid in the induce genetic damage (Dixit et al., 1985; from a diversity of flowering plant families.
    [Show full text]
  • Betanin, the Main Pigment of Red Beet
    Betanin, the main pigment of red beet - molecular origin of its exceptionally high free radical scavenging activity Anna Gliszczyńska-Świglo, Henryk Szymusiak, Paulina Malinowska To cite this version: Anna Gliszczyńska-Świglo, Henryk Szymusiak, Paulina Malinowska. Betanin, the main pigment of red beet - molecular origin of its exceptionally high free radical scavenging activity. Food Additives and Contaminants, 2006, 23 (11), pp.1079-1087. 10.1080/02652030600986032. hal-00577387 HAL Id: hal-00577387 https://hal.archives-ouvertes.fr/hal-00577387 Submitted on 17 Mar 2011 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Food Additives and Contaminants For Peer Review Only Betanin, the main pigment of red beet - molecular origin of its exceptionally high free radical scavenging activity Journal: Food Additives and Contaminants Manuscript ID: TFAC-2005-377.R1 Manuscript Type: Original Research Paper Date Submitted by the 20-Aug-2006 Author: Complete List of Authors: Gliszczyńska-Świgło, Anna; The Poznañ University of Economics, Faculty of Commodity Science
    [Show full text]
  • Steviol Glycoside Determination by HPLC with Charged Aerosol and UV Detections Using the Acclaim Trinity P1 Column
    Application Note: 293 Steviol Glycoside Determination by HPLC with Charged Aerosol and UV Detections Using the Acclaim Trinity P1 Column Deanna Hurum and Jeffrey Rohrer; Sunnyvale, CA USA Introduction Steviol glycoside determination is challenging for Key Words In December 2008, the U.S. FDA recognized rebaudioside multiple reasons. The structures of the steviol glycosides are quite similar, differing in small changes in glycosylation. For • Stevia A purified from Stevia rebaudiana (Bertoni) as Generally Recognized as Safe (GRAS) for use as a sugar substitute example, rebaudioside B, an impurity that can be formed • Rebaudioside A in foods.1,2 Since this recognition, stevia products have during processing of the leaves, differs in structure from rebaudioside A primarily by the presence or absence of a • HILIC become popular as table-top and beverage sweeteners. Although the stevia plant and extracts from stevia leaves glucose residue at the R1 position on the terpene (Figure 2). These • Natural have long been used as sweeteners in Asia and Latin structural similarities make chromatographic separation Sweeteners America, the terpene glycosides have different flavor difficult. In addition to the separation challenges, sensitive profiles with both sweet and unpleasant bitter flavors.3 detection of these compounds also can be difficult. They Two steviol glycosides, stevioside and rebaudioside A, are do not absorb strongly in the UV, and typical detection largely responsible for the desired sweet flavor of the leaves wavelengths for steviol glycosides, such as 210 nm, are (Figure 1), with rebaudioside A preferred for sweeteners.4 nonspecific. Other detection methods, such as charged aerosol, can be used in addition to UV detection to improve steviol glycoside quantification.
    [Show full text]
  • Application A1108 Rebaudioside M As a New Steviol Glycoside Intense
    Supporting document 1 Risk and technical assessment report – Application A1108 Rebaudioside M as a New Steviol Glycoside Intense Sweetener Executive summary Rebaudioside M is similar in chemical structure and sweetness intensity to other currently permitted steviol glycosides. The production of rebaudioside M preparations, analytical methods, specifications and stability are similar to other steviol glycosides. Rebaudioside M occurs naturally in the leaves of the stevia plant at much lower concentrations than several other steviol glycosides so specific concentration and purification steps are required to produce preparations containing high concentrations of rebaudioside M. As for other steviol glycosides, rebaudioside M is hydrolysed completely to steviol by gut microflora. The existing acceptable daily intake (ADI) for steviol glycosides of 0– 4 mg/kg bodyweight, which is expressed on the basis of steviol, is therefore applicable to rebaudioside M. Rebaudioside M-containing preparations are intended for use in the same food categories and at the same use-levels already permitted for other steviol glycoside products. FSANZ has previously conducted a dietary exposure assessment using the current permissions for steviol glycosides and therefore no dietary exposure assessment was necessary for this Application. It is concluded that the use of rebaudioside M as a food additive in accordance with the current permissions for steviol glycosides raises no public health and safety concerns. 1 Table of Contents EXECUTIVE SUMMARY ........................................................................................................................
    [Show full text]
  • Apricot Kernel Oil (AKO)
    RISK PROFILE Apricot kernel oil (AKO) C A S N o . 72869- 69- 3 Date of reporting 31.05.201 3 Content of document 1. Identification of substance ……………………………………………………… p. 1 2. Uses and origin ……………………………………………………… p. 7 3. Regulation ………………………………………………………………………… p. 10 4. Relevant toxicity studies ……………………………………………………… p. 10 5. Exposure estimates and critical NOAEL/NOEL …………………………………… p. 16 6. Other sources of exposure than cosmetic products …………………………. p. 19 7. Assessment ………………………………………………………………………… p. 23 8. Conclusion ………………………………………………………………………… p. 24 9. References ………………………………………………………………………… p. 25 10. Annexes ………………………………………………………………………… p. 29 1. Identification of substance Chemical name (IUPAC): Apricot kernel oil INCI PRUNUS ARMENIACA KERNEL OIL Synonyms Apricot oil CAS No. 72869-69-3 EINECS No. 272-046-1 / - Molecular formula Chemical structure Molecular weight Contents (if relevant) AKO is the fixed oil expressed from the kernels of the Apricot, Prunus armeniaca L., Rosaceae AKO meant for cosmetic purposes is usually produced by cold pressing of the kernel (seed) of wild (bitter) apricots (Asma BM et al 2007, Dwivedi DH et al 2008). A typical composition of such a seed is as follows (Azou Z et al 2009): (w/w) Risk profile Apricot kernel oil Page 1 of 36 Version date: 31MAY2013 Fat (triglycerides): 50.3 % Protein 27.8 % Sugar 11.3 % Fiber 3.1 % Moisture 5.5 % Ash 2.2 % Annex 1 shows a more detailed chemical composition of the seed according to the Phytochemical database of the American Department of Agriculture1. A combination of cold pressing and solvent extraction (petroleum ether, hexane, chloroform-methanol or methanol) yield an AKO that consists of the lipids 92 – 98 %. Besides, that oil consists of smaller amounts of phytosterols like beta-sitosterol.
    [Show full text]
  • GRAS Notice 821 for Glucosylated Steviol Glycosides
    GRAS Notice (GRN) No. 821 https://www.fda.gov/food/generally-recognized-safe-gras/gras-notice-inventory {Ri~(C~ij\;#~[Q) NOV I 9 2018 16 November 20 l 8 OFFICE OF FOOD ADDITIVE SAFETY Dr. Paulette Gaynor Office of Food Additive Safety (HFS-200) Center for Food Safety and Applied Nutrition (CFSAN) Food and Drug Administration 500 l Campus Drive College Park, MD 20740 USA Dear Dr. Gaynor: Re: GRAS Notice for High-Purity Glucosylated Steviol Glycosides In accordance with 21 CFR § 170 Subpart E consisting of§ 170.203 through 170.285, Haigen-BGG Natural Ingredients (HBNI) Limited [l 1038, 11/F, Tower A, Gateway Square No. 18, Xiaguangli, North Road East Third Ring, Chaoyang District, Beijing, China], as the notifier, is submitting one hard copy and one electronic copy (on CD), of all data and information supporting the company's conclusion that high-purity glucosylated steviol glycosides, as manufactured by HBNI, is GRAS under the specified conditions of use as a food ingredient on the basis of scientific procedures, and therefore are not subject to the premarket approval requirements of the Federal Food, Drug and Cosmetic Act. Information setting forth the basis for HBNI's GRAS conclusion, as well as a consensus opinion of an independent panel of experts, also are enclosed for review by the agency. l certify that the enclosed electronic files were scanned for viruses prior to submission and are thus certified as being virus-free using Symantec Endpoint Protection 12.1.5. Should you have any questions or concerns regarding this GRAS notice, please do not hesitate to contact me at any point during the review process so that we may provide a response in a timely manner.
    [Show full text]
  • Modes of Action of Herbal Medicines and Plant Secondary Metabolites
    Medicines 2015, 2, 251-286; doi:10.3390/medicines2030251 OPEN ACCESS medicines ISSN 2305-6320 www.mdpi.com/journal/medicines Review Modes of Action of Herbal Medicines and Plant Secondary Metabolites Michael Wink Institute of Pharmacy and Molecular Biotechnology, Heidelberg University, INF 364, Heidelberg D-69120, Germany; E-Mail: [email protected]; Tel.: +49-6221-544-881; Fax: +49-6221-544-884 Academic Editor: Shufeng Zhou Received: 13 August 2015 / Accepted: 31 August 2015 / Published: 8 September 2015 Abstract: Plants produce a wide diversity of secondary metabolites (SM) which serve them as defense compounds against herbivores, and other plants and microbes, but also as signal compounds. In general, SM exhibit a wide array of biological and pharmacological properties. Because of this, some plants or products isolated from them have been and are still used to treat infections, health disorders or diseases. This review provides evidence that many SM have a broad spectrum of bioactivities. They often interact with the main targets in cells, such as proteins, biomembranes or nucleic acids. Whereas some SM appear to have been optimized on a few molecular targets, such as alkaloids on receptors of neurotransmitters, others (such as phenolics and terpenoids) are less specific and attack a multitude of proteins by building hydrogen, hydrophobic and ionic bonds, thus modulating their 3D structures and in consequence their bioactivities. The main modes of action are described for the major groups of common plant secondary metabolites. The multitarget activities of many SM can explain the medical application of complex extracts from medicinal plants for more health disorders which involve several targets.
    [Show full text]
  • Quo Vadis Cardiac Glycoside Research?
    toxins Review Quo vadis Cardiac Glycoside Research? Jiˇrí Bejˇcek 1, Michal Jurášek 2 , VojtˇechSpiwok 1 and Silvie Rimpelová 1,* 1 Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technická 5, Prague 6, Czech Republic; [email protected] (J.B.); [email protected] (V.S.) 2 Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 3, Prague 6, Czech Republic; [email protected] * Correspondence: [email protected]; Tel.: +420-220-444-360 Abstract: AbstractCardiac glycosides (CGs), toxins well-known for numerous human and cattle poisoning, are natural compounds, the biosynthesis of which occurs in various plants and animals as a self-protective mechanism to prevent grazing and predation. Interestingly, some insect species can take advantage of the CG’s toxicity and by absorbing them, they are also protected from predation. The mechanism of action of CG’s toxicity is inhibition of Na+/K+-ATPase (the sodium-potassium pump, NKA), which disrupts the ionic homeostasis leading to elevated Ca2+ concentration resulting in cell death. Thus, NKA serves as a molecular target for CGs (although it is not the only one) and even though CGs are toxic for humans and some animals, they can also be used as remedies for various diseases, such as cardiovascular ones, and possibly cancer. Although the anticancer mechanism of CGs has not been fully elucidated, yet, it is thought to be connected with the second role of NKA being a receptor that can induce several cell signaling cascades and even serve as a growth factor and, thus, inhibit cancer cell proliferation at low nontoxic concentrations.
    [Show full text]
  • Amygdalin: Toxicity, Anticancer Activity and Analytical Procedures for Its Determination in Plant Seeds
    molecules Review Amygdalin: Toxicity, Anticancer Activity and Analytical Procedures for Its Determination in Plant Seeds Ewa Jaszczak-Wilke 1, Zaneta˙ Polkowska 1,* , Marek Koprowski 2 , Krzysztof Owsianik 2, Alyson E. Mitchell 3 and Piotr Bałczewski 2,4,* 1 Department of Analytical Chemistry, Faculty of Chemistry, Gdansk University of Technology, 11/12 Narutowicza Str., 80-233 Gdansk, Poland; [email protected] 2 Division of Organic Chemistry, Centre of Molecular and Macromolecular Studies, Polish Academy of Sciences, Sienkiewicza 112, 90-363 Łód´z,Poland; [email protected] (M.K.); [email protected] (K.O.) 3 Department of Food Science and Technology, University of California, Davis, One Shields Avenue, Davis, CA 95616, USA; [email protected] 4 Institute of Chemistry, Faculty of Science and Technology, Jan Długosz University in Cz˛estochowa, Armii Krajowej 13/15, 42-200 Cz˛estochowa,Poland * Correspondence: [email protected] (Z.P.);˙ [email protected] (P.B.) Abstract: Amygdalin (D-Mandelonitrile 6-O-β-D-glucosido-β-D-glucoside) is a natural cyanogenic glycoside occurring in the seeds of some edible plants, such as bitter almonds and peaches. It is a medically interesting but controversial compound as it has anticancer activity on one hand and can be toxic via enzymatic degradation and production of hydrogen cyanide on the other hand. Despite numerous contributions on cancer cell lines, the clinical evidence for the anticancer activity of amygdalin is not fully confirmed. Moreover, high dose exposures to amygdalin can produce cyanide Citation: Jaszczak-Wilke, E.; toxicity. The aim of this review is to present the current state of knowledge on the sources, toxicity Polkowska, Z.;˙ Koprowski, M.; and anticancer properties of amygdalin, and analytical methods for its determination in plant seeds.
    [Show full text]
  • Betacyanins and Betaxanthins in Cultivated Varieties of Beta Vulgaris L
    molecules Article Betacyanins and Betaxanthins in Cultivated Varieties of Beta vulgaris L. Compared to Weed Beets Milan Skalicky 1,* , Jan Kubes 1 , Hajihashemi Shokoofeh 2 , Md. Tahjib-Ul-Arif 3 , Pavla Vachova 1 and Vaclav Hejnak 1 1 Department of Botany and Plant Physiology, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences Prague, 16500 Prague, Czech Republic; [email protected] (J.K.); [email protected] (P.V.); [email protected] (V.H.) 2 Plant Biology Department, Faculty of Science, Behbahan Khatam Alanbia University of Technology, Khuzestan 47189-63616, Iran; [email protected] 3 Department of Biochemistry and Molecular Biology, Faculty of Agriculture, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh; [email protected] * Correspondence: [email protected]; Tel.: +420-22438-2520 Academic Editor: Krystian Marszałek Received: 21 October 2020; Accepted: 16 November 2020; Published: 18 November 2020 Abstract: There are 11 different varieties of Beta vulgaris L. that are used in the food industry, including sugar beets, beetroots, Swiss chard, and fodder beets. The typical red coloration of their tissues is caused by the indole-derived glycosides known as betalains that were analyzed in hypocotyl extracts by UV/Vis spectrophotometry to determine the content of betacyanins (betanin) and of betaxanthins (vulgaxanthin I) as constituents of the total betalain content. Fields of beet crops use to be also infested by wild beets, hybrids related to B. vulgaris subsp. maritima or B. macrocarpa Guss., which significantly decrease the quality and quantity of sugar beet yield; additionally, these plants produce betalains at an early stage.
    [Show full text]
  • Bristaflam Tablet Safety Guidance: Aceclofenac Is Contraindicated In
    Bristaflam Tablet Safety Guidance: Aceclofenac is contraindicated in: • patients with known hypersensitivity to aceclofenac or to any of the excipients, • active, or history of recurrent peptic ulcer/haemorrhage (two or more distinct episodes of proven ulceration or bleeding), • patients with histories of gastrointestinal bleeding or perforation, related to previous NSAIDs therapy (see Section Warnings and Precautions), • patients who have previously shown hypersensitivity reactions (e.g. asthma, rhinitis, angioedema or urticaria) in response to ibuprofen, aspirin, or other non-steroidal anti-inflammatory drugs, • patients with severe heart failure, • patients with severe hepatic and renal failure, • patients with active bleedings or bleeding disorders, • during the last trimester of pregnancy. Warnings and Precautions: • Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms. • The use of aceclofenac with concomitant NSAIDs including cyclooxygenase2- selective inhibitors should be avoided. • The elderly have an increased frequency of adverse reactions to NSAIDs especially gastrointestinal bleeding and respiratory disorder which may be fatal. • The administration of an NSAID may cause a dose dependent reduction in prostaglandin formation and precipitate renal failure. Patients at greatest risk of this reaction are those with impaired renal function, cardiac impairment, liver dysfunction, those taking diuretics or recovering from major surgery and the elderly. • Appropriate monitoring and advice are required for patients with a history of hypertension and/or mild to moderate congestive heart failure as fluid retention and oedema have been reported in association with NSAID therapy. • In patients with systemic lupus erythematosus and mixed connective tissue disorders there may be an increased risk of aseptic meningitis with symptoms such as stiff neck, headache, nausea, vomiting, fever or disorientation.
    [Show full text]